Patent · US Active

Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival

US10064914B2 · kind B2 · utility

4Cited by

0References

9Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Pinchas Cohen · Santa Monica, US
Changhan Lee · Incheon, KR

Key dates

Filing date	May 4, 2016
Grant date	Sep 4, 2018
Priority date	—
Expiry date	May 4, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

MOTS3 is a novel polypeptide. Methods of treating diseases such as diabetes, obesity, fatty liver, and cancer using MOTS3 and pharmaceutical compositions thereof are disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.